GSK's lung cancer treatment secures "orphan drug" status in Japan
(Alliance News) - GSK PLC on Monday said Japanese health authorities had granted "orphan drug" status to its lung cancer treatment. Read More
| Price | 1,957.50p on 23-03-2026 at 15:10:48 |
|---|---|
| Change | 7.00p 0.36% |
| Buy | 1,958.00p |
| Sell | 1,957.00p |
| Last Trade: | Sell 98.00 at 1,957.00p |
| Day's Volume: | 6,009,039 |
| Last Close: | 1,950.50p |
| Open: | 1,926.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,906.50p - 1,966.50p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £78.34b |
| VWAP: | 1,936.67177p |
| Shares in Issue: | 4.00b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 98 | 1,957.00p | Automatic Execution |
15:10:43 - 23-Mar-26 |
| Sell* | 82 | 1,957.00p | Automatic Execution |
15:10:43 - 23-Mar-26 |
| Sell* | 202 | 1,957.00p | Automatic Execution |
15:10:43 - 23-Mar-26 |
| Buy* | 77 | 1,957.50p | SI Trade |
15:10:38 - 23-Mar-26 |
| Sell* | 2,776 | 1,957.00p | SI Trade |
15:10:38 - 23-Mar-26 |
| Sell* | 100 | 1,957.00p | Automatic Execution |
15:10:38 - 23-Mar-26 |
| Buy* | 320 | 1,957.50p | Automatic Execution |
15:10:36 - 23-Mar-26 |
| Buy* | 100 | 1,957.50p | Automatic Execution |
15:10:36 - 23-Mar-26 |
| Buy* | 687 | 1,957.00p | Automatic Execution |
15:10:36 - 23-Mar-26 |
| Buy* | 422 | 1,957.00p | Automatic Execution |
15:10:36 - 23-Mar-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 19th Mar 2026 12:00 pm | RNS | Lynavoy (linerixibat) approved by US FDA |
| 19th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 18th Mar 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 18th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Mar 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 17th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Mar 2026 7:00 am | RNS | Transaction in Own Shares |